Naushad(Shaik Mohammad),Hussain(Tajamul),A... Mol Cell Biochem 2015-02-24

...RalGDS/AF-6) domain family member 1 (RASSF1A) (r = 0.31, p < 0.001), and breast cancer type 1 susceptibility protein (r ...

Mazhab-Jafari(Mohammad T),Marshall(Christo... Proc Natl Acad Sci U S A 2015-08-28

...RALGDS) proteins. Gain-of-function KRAS mutations occur frequently in human cancers and predict poor clinical outcome, w...

Kanekiyo(Shinsuke),Iizuka(Norio),Tsunedomi... Anticancer Res 2015-04-09

...RalGDS/AF-6) domain family member 1, serine peptidase inhibitor Kunitz type 2, cystic fibrosis transmembrane conductance...

Sebestyén(Endre),Zawisza(Michał),Eyras(Edu... Nucleic Acids Res 2015-06-18

...RALGDS, MITF, PRDM1, ABI1 and MYH11, for which the switch implies a change in the protein product. Moreover, some of the...

Villanueva(Augusto),Portela(Anna),Sayols(S... Hepatology 2015-08-04

...RalGDS/AF-6] domain family member 1, insulin-like growth factor 2, and adenomatous polyposis coli) and other solid tumor...

Ezzeldin(Mohamad),Borrego-Diaz(Emma),Taha(... Mol Oncol 2015-02-21

...RalGDS were also expressed at higher levels in malignant samples. Inhibition of RalA by gene-specific silencing caused a...

Walker(David M),Wang(Ruifei),Webb(Lauren J... Phys Chem Chem Phys 2015-10-16

...RalGDS) to make comparisons between the docked complexes formed when either of the two effectors bind to WT Ras. This co...

Zhou(Xu-Hui),Yang(Chao-Qun),Zhang(Cheng-Li... Oncol Rep 2015-06-01

...RalGDS/AF-6) domain family member RASSF5 has been implicated in a variety of key biological processes, including cell pr...

Pallegar(Nikitha K),Ayre(D Craig),Christia... Front Cell Dev Biol 2015-08-24

...RalGDS pathway only partially affected protein expression. Surprisingly, inhibition of MEK with U0126 only partially res...

Ma(Yi-hui),Zhang(Qiang),Gu(Yu-mei),Lu(Chao... Zhongguo Yi Xue Ke Xue Yuan... 2014-01-09

...RalGDS, and the function domain of F-Box as well as the U-Box to construct the plasmids. Then used the double enzyme, PC...